World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
35766
World Ranking
13923
National Ranking
7067

Overview

Steven M. Devine is affiliated with The Ohio State University in the United States and has a significant research profile in the field of medicine, specifically focusing on hematology, transplantation, and oncology. Their work encompasses multiple subfields such as public health, environmental and occupational health, immunology, and transplantation, underpinning a comprehensive approach to hematopoietic and cancer research.

Their research primarily addresses key topics including hematopoietic stem cell transplantation, acute myeloid leukemia research, acute lymphoblastic leukemia research, renal transplantation outcomes and treatments, chronic myeloid leukemia treatments, immune cell function and interaction, and cancer genomics and diagnostics.

Steven M. Devine has published extensively in several well-known venues, reflecting their active engagement within the scientific community. Frequent publication venues include:

  • Transplantation and Cellular Therapy
  • Blood
  • Blood Advances
  • Biology of Blood and Marrow Transplantation
  • Journal of Clinical Oncology

Some recent papers authored or co-authored by Steven M. Devine are:

  • Current Use of and Trends in Hematopoietic Cell Transplantation in the United States, 2020, Biology of Blood and Marrow Transplantation
  • Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial, 2020, Blood
  • National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide, 2021, Journal of Clinical Oncology
  • Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3, 2024, Journal of Clinical Oncology
  • DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant, 2023, JAMA

Their collaborations include frequent co-authorship with several other scientists. Notable co-authors include:

  • Bronwen E. Shaw
  • Stephen R. Spellman
  • Jeffery J. Auletta
  • Brent R. Logan
  • Heather E. Stefanski

Steven M. Devine's contribution to the literature is predominantly centered on hematopoietic stem cell transplantation and leukemia research, with a strong emphasis on transplantation outcomes, immune interactions, and genomic diagnostics. Their scholarly output, spanning multiple years, presents a detailed and evolving perspective on treatments and clinical trials related to blood and marrow transplantation.

Best Publications

  • Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

    Amelia Bartholomew;Cord Sturgeon;Mandy Siatskas;Karen Ferrer

  • Lenalidomide after stem-cell transplantation for multiple myeloma

    Philip L. McCarthy;Kouros Owzar;Craig C. Hofmeister;David D. Hurd

  • Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

    Hillard M. Lazarus;Omer N. Koc;Steven M. Devine;Peter Curtin

  • Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

    Steven M Devine;Carrington Cobbs;Matt Jennings;Amelia Bartholomew

  • The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

    Don M. Benson;Courtney E. Bakan;Anjali Mishra;Craig C. Hofmeister

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

    Voravit Ratanatharathorn;Richard A. Nash;Donna Przepiorka;Steven M. Devine

  • Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

    Claudio G. Brunstein;Ephraim J. Fuchs;Shelly L. Carter;Chatchada Karanes

  • Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

    Stefan O. Ciurea;Mei Jie Zhang;Andrea A. Bacigalupo;Asad Bashey

  • International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

    Andrew C. Harris;Andrew C. Harris;Rachel Young;Rachel Young;Steven Devine;William J. Hogan

  • The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

    Neal Flomenberg;Steven M. Devine;John F. DiPersio;Jane L. Liesveld

  • Current Use and Trends in Hematopoietic Cell Transplantation in the United States

    Anita D'Souza;Anita D'Souza;Stephanie Lee;Stephanie Lee;Xiaochun Zhu;Marcelo Pasquini;Marcelo Pasquini

  • Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion

    Steven M. Devine;Amelia M. Bartholomew;Nadim Mahmud;Mary Nelson

  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

    Bart L. Scott;Marcelo C. Pasquini;Brent R. Logan;Juan Wu

  • Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

    Steven M. Devine;Neal Flomenberg;David H. Vesole;Jane Liesveld

  • Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

    William Blum;Ramiro Garzon;Rebecca B. Klisovic;Sebastian Schwind

  • Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

    Philippe Armand;Arnon Nagler;Edie A. Weller;Steven M. Devine

  • CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma

    Jianhong Chu;Youcai Deng;Don M. Benson;Shun He

  • Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations

    Sergio Giralt;Luciano Costa;Jeffrey Schriber;John DiPersio

  • Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

    Robert J. Soiffer;Jennifer LeRademacher;Vincent Ho;Fangyu Kan

Frequent Co-Authors

Don M. Benson
Don M. Benson The Ohio State University
John C. Byrd
John C. Byrd University of Pittsburgh Cancer Institute
Guido Marcucci
Guido Marcucci City Of Hope National Medical Center
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Robert J. Soiffer
Robert J. Soiffer Harvard University
Ravi Vij
Ravi Vij Washington University in St. Louis
Michael R. Grever
Michael R. Grever The Ohio State University
Jianhua Yu
Jianhua Yu City Of Hope National Medical Center
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
John F. DiPersio
John F. DiPersio Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA often leads students beyond the traditional MD route. Many online degrees provide faster and more flexible pathways into healthcare roles. For those interested in advancing in nursing, options like the quickest dnp program can help experienced nurses earn a Doctor of Nursing Practice degree in less time.

If you need a less demanding academic load or are looking for more manageable coursework, the easiest dnp program online highlights several programs that focus on flexibility and accessibility. These are ideal for working professionals balancing education with personal commitments.

Entry-level opportunities like becoming a Licensed Practical Nurse can also be streamlined. The fast track lpn programs allow you to start working in healthcare sooner, with many options offered entirely online.

Psychiatry and mental health are growing fields, and if you want to specialize, the fastest psychiatric nurse practitioner program can help you qualify for these high-demand roles quickly and efficiently.

Best Scientists Citing Steven M. Devine

Trending Scientists

Recently Published Articles